Pulmo BioTech Inc.

Welcome to Pulmo BioTech

• Pulmo BioTech Inc is a development stage public company which intends to bring innovative and exciting molecular imaging medical diagnostic technologies to the marketplace.
• Our current product candidate is a molecular imaging molecule which is designed for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory disorders.
• The brand name for our product candidate is “PulmoBind”.
• We have completed Pre-Clinical trials of PulmoBind and are anticipating starting Phase I Human Trials shortly.
• If PulmoBind is successful in its Phase Trials, we believe that it will quickly replace the incumbent technology for the Nuclear Medicine based diagnosis of Pulmonary Embolism, and will further create new markets for the diagnosis of Pulmonary Hypertension, Chronic Obstructive Pulmonary Disorder (COPD) and other disorders afflicting the pulmonary circulatory system.

© 2011 Pulmo BioTech Incorporated